Home

GEORGE H CONRADES

CIK 1106231 · Executive Chairman · last filed 2025-06-20

GEORGE H CONRADES is an Executive Chairman who has filed 124 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing shows the insider sold $1.7M of ORCL on Jun 20, 2025. Across all open-market trades the lifetime net is −$16.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $81.9M across reported positions. 36 SEC filings were submitted jointly with IRONWOOD PHARMACEUTICALS INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$81.89M

Companies

6

Total Filings

124

Lifetime Open-Market Net

-$16.45M

Filer Profile

Reported Address
500 TECHNOLOGY SQUARE
FIFTH FLOOR
CAMBRIDGE, MA 02139
Formerly Known As
CONRADES GEORGE N (2000–2003)
Related Filers
IRONWOOD PHARMACEUTICALS INC — 36 joint filings, latest 2015-06-05
ORACLE CORP — 36 joint filings, latest 2025-06-20
CARDINAL HEALTH INC — 23 joint filings, latest 2008-11-19
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ORCL Director 38,456 $143.90 $5.53M -$19.61M 29 2025-06-20
CYCN Director 31 $23.52 $729 $0 6 2022-06-16
AKAM Director 682,257 $105.56 $72.02M $5.92M 29 2018-05-22
HOG Director 52,573 $27.59 $1.45M -$2.75M 13 2015-08-17
IRWD Director 545,976 $4.14 $2.26M $0 33 2015-06-05
CAH Director 2,653 $234.69 $622.6K $0 9 2008-11-19

Recent Filings

124 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2025-06-20 ORCL Sell (S) −8,169 -$1.74M EDGAR
2025-06-17 ORCL Notice (144) −8,169 -$1.74M EDGAR
2025-06-03 ORCL Mixed +2,986 $0 EDGAR
2025-04-23 ORCL Exer (M) +22,500 $978.5K EDGAR
2024-06-03 ORCL Mixed +3,303 $0 EDGAR
2024-05-06 ORCL Mixed — -$1.48M EDGAR
2024-05-03 ORCL Notice (144) −20,000 -$2.32M EDGAR
2024-05-02 ORCL Mixed — -$1.85M EDGAR
2024-05-01 ORCL Notice (144) −25,000 -$2.90M EDGAR
2023-11-13 ORCL Notice (144) −2,325 -$264.5K EDGAR
Showing 1–10 of 124
Page 1 of 13
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.